SurGenTec, LLC appears in FDA 510(k) records as the applicant for two devices decided in late 2026, both filed from a Boca Raton, Florida address. The Vantage Lumbar Decompression Kit, K263208, was received September 14, 2026 and decided October 14, 2026 as substantially equivalent under product code HRX, regulation 888.1100 (Arthroscope), class II, orthopedic advisory committee, with a Special clearance type and a summary statement. The Durashield Device Kit, K252995, was received September 18, 2025 and decided September 17, 2026 as substantially equivalent under product code GZT, regulation 882.4800 (self-retaining retractor for neurosurgery), class II, neurology advisory committee, Traditional clearance type, also with a summary statement. Neither filing was reviewed by a third party. [1][2]
The Vantage Lumbar Decompression Kit filing
K263208 covers a device named Vantage Lumbar Decompression Kit, classified under the arthroscope regulation and assigned to the orthopedic panel. The record lists SurGenTec, LLC as applicant with contact Richard Sharp at 911 Clint Moore Rd., Boca Raton, FL 33487, and shows a Special clearance type with a summary statement and no third-party review. The FDA 510(k) database entry for this number is the only filing-level detail supplied for the device. [1]
A separate FDA summary letter, K252546, dated March 12, 2026, names Allevion Medical, LLC of 915 Clint Moore Rd, Boca Raton, Florida, as the applicant for a device also called Vantage Lumbar Decompression Kit, under the same regulation 888.1100 and product codes HRX and HAE, with a Traditional clearance decided substantially equivalent. That letter identifies a different legal applicant and a different 510(k) number, so it documents a separate clearance rather than SurGenTec's K263208. [8][9]
The Durashield Device Kit filing
K252995 covers the Durashield Device Kit under product code GZT, regulation 882.4800, the self-retaining retractor classification for neurosurgery, with a neurology advisory committee assignment. The applicant is SurGenTec, LLC at the same Boca Raton address, contact Richard Sharp. The decision date is September 17, 2026, roughly a year after the September 18, 2025 receipt date, and the record shows a Traditional clearance type, a summary statement and no third-party review. [2]
Company statements and product framing
SurGenTec's own website describes it as a privately owned medical device company that develops and manufactures products, working with surgeons, experts and distributors, and lists Boca Raton, Florida, USA in its footer alongside the 911 Clint Moore Road address and a customer service email. Those are publisher statements about the company, not FDA findings, and the site does not name a parent organization. [7]
The company's Vantage page describes the Vantage system as a three-step process of locating, visualizing and decompressing, using a working cannula and rongeurs to remove bony elements, and states that each component is sterile and single-use. The same page invites distributor inquiries. These are manufacturer descriptions of intended design and use; the supplied filings do not include performance data for the device. [5]
The company homepage lists other products, including the TILINK-P SI Joint Fusion System, the ION-C Cervical Implant System, OsteoFlo HydroFiber, TILINK-L, 3D GraftRasp and FacetCore, and references Spine Summit 2027. None of those products appears in the two supplied 510(k) records, so their regulatory status is not established here. [10]
What the collection shows and does not show
The supplied collection contains two linked 510(k) records, both decided substantially equivalent, and no recall records. That count reflects the retrieved snapshot as of November 20, 2026, not total company sales, total portfolio or safety performance. An establishment registration and device listing search for the proprietary name Vantage Lumbar returned two results, but the supplied excerpt does not identify the establishments or registration numbers. [6]
